Vimarsana
Biggest News Aggregation in the World

Value Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Value Drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Value Drug Today - Breaking & Trending Today

D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain Permissible Under The Patent Act - Antitrust, EU Competition - Vimarsana News

D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain Permissible Under The Patent Act - Antitrust, EU Competition

On Friday, August 25, 2023, the U.S. Court of Appeals For The District Of Columbia Circuit affirmed dismissal of an antitrust action brought by the Federal Trade Commission...

Source: mondaq.com
TraceLink and Value Drug Partner on Drug Supply Chain Security Act (DSCSA) 2023 Compliance to Reduce Cost for Pharmacies - Vimarsana News

TraceLink and Value Drug Partner on Drug Supply Chain Security Act (DSCSA) 2023 Compliance to Reduce Cost for Pharmacies

/PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000...

Pharmaceutical Industry Leaders Accelerate DSCSA Compliance, Lay Foundation for End-to-End Supply Chain Visibility at FutureLink 2023 - Vimarsana News

Pharmaceutical Industry Leaders Accelerate DSCSA Compliance, Lay Foundation for End-to-End Supply Chain Visibility at FutureLink 2023

/PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000...

In the news on this date: May 4 | News, Sports, Jobs - Vimarsana News

In the news on this date: May 4 | News, Sports, Jobs

Local history 50 years ago: 1973 In ceremonies at DelGrosso’s Restaurant in Tipton, George’s TV of Altoona, owned by George Thomas and opened in 1966, w

Lack Of Facts Dooms Class Cert Over Takeda Gout Drug - Vimarsana News

Lack Of Facts Dooms Class Cert Over Takeda Gout Drug

A federal judge last week rejected a bid by pharmacy chain Value Drug Co. to certify a class of roughly 50 purchasers of Takeda Pharmaceuticals' anti-gout drug Colcrys alleging that the company engaged in anticompetitive deals to stave off generic competition.

Source: law360.com